XML 37 R21.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jan. 31, 2017
Accounting Policies [Abstract]  
Schedule of Inventories

. Inventory was comprised of the following at January 31, 2017 and 2016:

 

    January 31, 2017     January 31, 2016  
Finished goods   $ 443,623     $ 252,752

Schedule of Property and Equipment Estimated Useful Lives

Asset lives for financial statement reporting of depreciation are:

 

Machinery and equipment 2-7 years
Furniture and fixtures 3 years
Leasehold improvements 5 years

Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

 

    Year Ended
January 31, 2017
    Year Ended
January 31, 2016
 
Gross Sales   $ 18,498,142     $ 13,138,214  
Less: Slotting, Discounts, Allowances     449,350       534,767  
Net Sales   $ 18,048,792     $ 12,603,447

Schedule of Fair Value of Share-Based Payments

For the years ended January 31, 2017 and 2016, when computing fair value of share-based payments, the Company has considered the following variables:

 

    January 31, 2017     January 31, 2016  
Risk-free interest rate     1.25% to 1.90 %     1.42% to 1.74 %
Expected life of grants     2.5 years       2.5 years  
Expected volatility of underlying stock     139% to 179 %     178% to 184 %
Dividends     0 %     0 %

Schedule of Common Stock Equivalents

The Company had the following potential common stock equivalents at January 31, 2017:

 

Series A Preferred     3,466,667  
Common stock warrants, exercise price range of $0.68-$2.50     7,311,770  
Common stock options, exercise price of $0.39-$2.97     881,404  
Total common stock equivalents     11,659,841  

 

The Company had the following potential common stock equivalents at January 31, 2016:

 

Series A Preferred     3,466,667  
Common stock warrants, exercise price range of $0.675-$2.50     4,964,734  
Common stock options, exercise price of $1.00-$2.97     496,404  
Total common stock equivalents     8,927,805